ARCHIVES

News Analysis by Keith Baggerly: Duke Trials Went On Despite FDA Statements

This article is from The Cancer Letter archive.

Vol. 38 No. 04 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

NTP Board Okays concept for New In Vitro study Using Oncogenes

May 10, 1985

Self-Collected Pap Smear Tests Could Advance HPV Screening

January 27, 2012

Book For Survivors, Other New Publications

August 23, 1991

NCI-Approved Clinical Trials

July 30, 2010

Clinical Center, NCI, NHLBI, Form Center For Interventional Oncology

April 24, 2009

Adverse data from cancer prevention trial makes Merck withdraw Vioxx from market. Researchers discuss implications for other cancer prevention trials.

October 15, 2004